journal article·2026-01Open access

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro

Advanced Healthcare Materials· Volume 15· Issue 1

Abstract

Abstract The tumor microenvironment (TME) is a complex and dynamic ecosystem increasingly recognized for its interplay with the microbiome. In colorectal, breast, lung, liver, and brain cancers, bacterial communities and their metabolites are shown to influence tumor progression, immune responses, and therapeutic outcomes. To study these interactions in physiologically relevant contexts, advanced 3D in vitro models have emerged, including spheroids, organoids, microfluidic organ‐on‐a‐chip platforms, and 3D‐bioprinted constructs. These systems provide spatial organization, mechanical cues, and co‐culture capabilities that facilitate investigation of host–microbiome–tumor cross‐talk. Incorporation of live bacteria, their metabolites, and immune components into these platforms has yielded new insights into how the microbiome shapes cancer behavior, inflammation, and drug resistance. This review outlines recent advances in 3D model development for studying tumor–microbiome interactions, highlighting organ‐specific applications, extracellular matrix‐mimicking hydrogels, and biofabrication strategies. It also addresses key challenges, including maintaining microbiome viability, modeling temporal dynamics, and integrating immune complexity. Overcoming these limitations requires interdisciplinary approaches that merge bioengineering, microbiology, and oncology. Evolving 3D platforms offer powerful tools for microbiome‐informed cancer modeling and hold significant promise for advancing therapeutic screening and precision oncology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Innovative Microfluidic and Catalytic Techniques Innovation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology and Pharmacology Gray School of Medical Sciences Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv 6997801 Israel

Sagol School of Neuroscience Tel Aviv University Tel Aviv 6997801 Israel

Tel Aviv University Center for Nanoscience and Nanotechnology Tel Aviv University Tel Aviv 6997801 Israel

Funding

Israel Science Foundation

References (100+)

Show source-provided references
1. 10.1186/s43556-025-00248-910.1186/s43556-025-00248-9 ↗
2. 10.1007/s10555-025-10256-410.1007/s10555-025-10256-4 ↗
3. 10.1007/s11427-024-2831-x10.1007/s11427-024-2831-x ↗
4. 10.1038/nrc285710.1038/nrc2857 ↗
5. 10.1038/s41419-024-07318-w10.1038/s41419-024-07318-w ↗
6. 10.3389/fimmu.2022.105198710.3389/fimmu.2022.1051987 ↗
7. Li W. · Fundamental Research · 2023 · 2667
8. 10.3892/ijo.2024.566110.3892/ijo.2024.5661 ↗
9. 10.3389/fimmu.2024.145603010.3389/fimmu.2024.1456030 ↗
10. 10.1080/19490976.2024.237459610.1080/19490976.2024.2374596 ↗
11. 10.3389/fcimb.2024.140946410.3389/fcimb.2024.1409464 ↗
12. 10.1126/science.aah504310.1126/science.aah5043 ↗
13. 10.1126/science.aan370610.1126/science.aan3706 ↗
14. 10.1126/science.aac425510.1126/science.aac4255 ↗
15. 10.1093/annonc/mdy10310.1093/annonc/mdy103 ↗
16. 10.3389/fimmu.2024.137350410.3389/fimmu.2024.1373504 ↗
17. 10.1038/s41571-018-0006-210.1038/s41571-018-0006-2 ↗
18. 10.3389/fonc.2022.102903310.3389/fonc.2022.1029033 ↗
19. 10.1038/s41522-025-00786-810.1038/s41522-025-00786-8 ↗
20. 10.1016/j.jare.2023.11.02710.1016/j.jare.2023.11.027 ↗
21. 10.1158/1078-0432.CCR-20-344510.1158/1078-0432.CCR-20-3445 ↗
22. 10.1016/B978-0-12-823966-7.00003-710.1016/B978-0-12-823966-7.00003-7 ↗
23. 10.1002/ijc.291034010510.1002/ijc.2910340105 ↗
24. 10.1038/nature0624410.1038/nature06244 ↗
25. 10.1053/j.gastro.2011.07.05010.1053/j.gastro.2011.07.050 ↗
26. 10.1126/sciadv.abi911910.1126/sciadv.abi9119 ↗
27. 10.1039/C3LC51093J10.1039/C3LC51093J ↗
28. 10.1016/j.jconrel.2025.11381210.1016/j.jconrel.2025.113812 ↗
29. 10.1056/NEJMoa00199910.1056/NEJMoa001999 ↗
30. 10.1039/c2lc40074j10.1039/c2lc40074j ↗
31. 10.1038/ncomms1153510.1038/ncomms11535 ↗
32. 10.1186/s12920-019-0569-510.1186/s12920-019-0569-5 ↗
33. 10.1038/s41591-025-03608-810.1038/s41591-025-03608-8 ↗
34. 10.1016/j.cell.2022.02.02710.1016/j.cell.2022.02.027 ↗
35. 10.1016/j.isci.2020.10187810.1016/j.isci.2020.101878 ↗
36. 10.1038/s41568-022-00514-w10.1038/s41568-022-00514-w ↗
37. 10.1016/j.addr.2021.04.00110.1016/j.addr.2021.04.001 ↗
38. 10.3390/cancers1312297010.3390/cancers13122970 ↗
39. 10.1002/ijc.3529810.1002/ijc.35298 ↗
40. 10.3389/fmicb.2021.73556210.3389/fmicb.2021.735562 ↗
41. 10.3390/microorganisms905106210.3390/microorganisms9051062 ↗
42. 10.1016/j.micres.2023.12733610.1016/j.micres.2023.127336 ↗
43. 10.3389/fbioe.2025.150596310.3389/fbioe.2025.1505963 ↗
44. 10.1016/j.biotechadv.2016.11.00210.1016/j.biotechadv.2016.11.002 ↗
45. 10.1016/j.micpath.2023.10642910.1016/j.micpath.2023.106429 ↗
46. 10.1038/nprot.2008.22610.1038/nprot.2008.226 ↗
47. 10.1186/1741-7007-10-2910.1186/1741-7007-10-29 ↗
48. 10.1177/1535370223119805010.1177/15353702231198050 ↗
49. 10.1007/s44164-023-00059-810.1007/s44164-023-00059-8 ↗
50. 10.1186/s12929-024-00997-910.1186/s12929-024-00997-9 ↗
51. 10.1007/7651_2024_52710.1007/7651_2024_527 ↗
52. Razian G. · J Vis Exp. · 2013 · 81
53. 10.1371/journal.pone.027624810.1371/journal.pone.0276248 ↗
54. 10.1038/s41598-020-78591-w10.1038/s41598-020-78591-w ↗
55. 10.1158/1078-0432.CCR-16-159910.1158/1078-0432.CCR-16-1599 ↗
56. 10.3389/fonc.2023.114893010.3389/fonc.2023.1148930 ↗
57. S. H.Kasper C.Morell‐Perez T. P.Wyche T. R.Sana L. A.Lieberman E. C.Hett Colorectal cancer‐associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment
58. 10.37349/etat.2024.0022610.37349/etat.2024.00226 ↗
59. 10.1038/s41598-020-78359-210.1038/s41598-020-78359-2 ↗
60. 10.1016/j.cell.2016.05.08210.1016/j.cell.2016.05.082 ↗
61. 10.1038/s41568-018-0007-610.1038/s41568-018-0007-6 ↗
62. 10.3389/fonc.2025.143250610.3389/fonc.2025.1432506 ↗
63. 10.1055/s-0042-175666210.1055/s-0042-1756662 ↗
64. 10.1038/s41416-020-0993-510.1038/s41416-020-0993-5 ↗
65. 10.1016/j.bioactmat.2023.06.00410.1016/j.bioactmat.2023.06.004 ↗
66. 10.1038/nature2016810.1038/nature20168 ↗
67. 10.7554/eLife.2913210.7554/eLife.29132 ↗
68. Li X. · Nat. Commun. · 2018 · 9
69. 10.1016/j.cell.2017.11.01010.1016/j.cell.2017.11.010 ↗
70. 10.1002/advs.20190034410.1002/advs.201900344 ↗
71. 10.1038/nature1227110.1038/nature12271 ↗
72. 10.1016/j.mtbio.2024.10143810.1016/j.mtbio.2024.101438 ↗
73. 10.1126/science.aao277410.1126/science.aao2774 ↗
74. 10.1016/j.anaerobe.2025.10294910.1016/j.anaerobe.2025.102949 ↗
75. 10.3389/fmicb.2019.0087910.3389/fmicb.2019.00879 ↗
76. 10.1053/j.gastro.2020.03.02110.1053/j.gastro.2020.03.021 ↗
77. 10.1038/s41573-020-0079-310.1038/s41573-020-0079-3 ↗
78. 10.1126/sciadv.abc233110.1126/sciadv.abc2331 ↗
79. 10.1056/NEJMoa06384210.1056/NEJMoa063842 ↗
80. 10.1039/C6LC00910G10.1039/C6LC00910G ↗
81. 10.1073/pnas.110531610810.1073/pnas.1105316108 ↗
82. 10.1039/C7LC00155J10.1039/C7LC00155J ↗
83. 10.1002/adma.20200297410.1002/adma.202002974 ↗
84. 10.1007/s10456-022-09842-910.1007/s10456-022-09842-9 ↗
85. 10.1016/j.biomaterials.2019.11954710.1016/j.biomaterials.2019.119547 ↗
86. 10.1038/s41551-019-0497-x10.1038/s41551-019-0497-x ↗
87. 10.1038/s41551-022-00882-610.1038/s41551-022-00882-6 ↗
88. 10.1039/C5LC00392J10.1039/C5LC00392J ↗
89. 10.1021/ac050131o10.1021/ac050131o ↗
90. 10.1021/acs.analchem.9b0142910.1021/acs.analchem.9b01429 ↗
91. 10.1039/C8LC00336J10.1039/C8LC00336J ↗
92. 10.3389/fimmu.2019.0113310.3389/fimmu.2019.01133 ↗
93. 10.1039/C7LC00878C10.1039/C7LC00878C ↗
94. 10.1186/s40580-022-00306-w10.1186/s40580-022-00306-w ↗
95. 10.1038/s41570-022-00420-710.1038/s41570-022-00420-7 ↗
96. 10.1016/j.actbio.2019.03.04010.1016/j.actbio.2019.03.040 ↗
97. 10.1038/micronano.2017.2510.1038/micronano.2017.25 ↗
98. 10.1038/s41598-022-22439-y10.1038/s41598-022-22439-y ↗
99. 10.1038/ncomms227110.1038/ncomms2271 ↗
100. 10.1039/D0RA08566A10.1039/D0RA08566A ↗